Inicio » Laboratories » Laboratory of Humanized Models of Disease

Laboratory of Humanized Models of Disease



Astrocytes constitute a large part of the brain cell mass and play an essential role in the central nervous system (CNS) by maintaining brain homeostasis. They also extensively interact with neurons and other brain cells providing trophic and metabolic support, stimulating synaptogenesis and neurotransmission and controlling blood flow. In disease and following injury, astrocytes acquire different reactive states characterized by specific molecular profiles, as well as biochemical, morphological and metabolic signatures which ultimately result in altered functions (Preman et al., Cells 2021).

Astrocytes become affected at early stages of Alzheimer’s disease (AD) (Arranz et al., Lancet Neurology 2019), however, we still know very little about human astrocyte reactivity and how reactive astrocytes crosstalk with other brain cells in AD. Do human astrocytes acquire specific reactive states during the course of AD? And, how such states impact and modulate the AD pathology?

We are using the stem cell technology to generate human astrocytes and other brain cells, and humanized in vitro modeling together with chimeric mice (Preman et al., Mol Neurodegener 2021; Espuny et al., Neuron 2017) to analyze human astrocyte reactive states, their interaction with other CNS cells and their contribution to the onset and progression of AD.



Primary cultures, culture and differentiation of human pluripotent stem cells (hESC/hiPSC); in vitro models of AD and chimeric mice; calcium imaging; neurotoxicity assays; fluorescent-activated cell sorting; qPCR; western blot; immunofluorescence; light, confocal and electron microscopy.

Latest publications

  1. Centenarian hippocampus displays high levels of astrocytic metallothioneins

    Saenz-Antoñanzas, Ander; Muñoz-Culla, Maider; Rigo, Piero; Ruiz-Barreiro, Leire; (...), ; Arranz Mendiguren, Amaia; Otaegui, David; Guillemot, François; Matheu, Ander
    Aging Cell (May, 2024) DOI: 10.1111/acel.14201
  2. A neuron-specific interaction between Alzheimer’s disease risk factors SORL1, APOE, and CLU

    Preman, Pranav; Arranz, Amaia M.
    Cell Reports (Sep, 2023) DOI: 10.1016/j.celrep.2023.113129
  3. MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer’s disease

    Balusu, Sriram; Horré, Katrien; Thrupp, Nicola; Craessaerts, Katleen; Snellinx, An; Serneels, Lutgarde; T’Syen, Dries; Chrysidou, Iordana; Arranz Mendiguren, Amaia; (...), ; Fiers, Mark; De Strooper, Bart
    Science (Sep, 2023) DOI: 10.1126/science.abp9556
  4. hiPSC-based models to decipher the contribution of human astrocytes to Alzheimer’s disease and potential therapeutics

    TCW, Julia; Arranz, Amaia M.
    Molecular Neurodegeneration (Mar, 2023) DOI: 10.1186/s13024-023-00612-9
  5. Evolution of neuroglia

    Verkhratsky, Alexei; Arranz, Amaia M.; Ciuba, Katarzyna; Pękowska, Aleksandra
    Annals of the New York Academy of Sciences (Dec, 2022) DOI: 10.1111/nyas.14917
  6. Human iPSC-derived astrocytes transplanted into the mouse brain undergo morphological changes in response to amyloid-β plaques

    Preman, Pranav; TCW, Julia; Calafate, Sara; Snellinx, An; Alfonso-Triguero, Maria; Corthout, Nikky; Munck, Sebastian; Thal, Dietmar Rudolf; Goate, Alison M.; De Strooper, Bart; Arranz, Amaia M.
    Molecular Neurodegeneration (Sep, 2021) DOI: 10.1186/s13024-021-00487-8
  7. Astrocytes in Alzheimer’s Disease: Pathological Significance and Molecular Pathways

    Preman, Pranav; Alfonso-Triguero, Maria; Alberdi, Elena; Verkhratsky, Alexei; Arranz, Amaia M.
    Cells (Mar, 2021) DOI: 10.3390/cells10030540